It’s official: Blackmores Limited is moving into the medical cannabis sector

Blackmores Limited (ASX:BKL) is the latest business to enter the hot pot stock sector.

| More on:
A jar of medicinal cannabis buds and a few buds on a table

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Pot stocks have spent most of 2017 smoking the ASX as investors pile into the medical cannabis sector to send the likes of MMJ Phytotech Ltd (ASX: MMJ), Creso Pharma Ltd (ASX: CPH) and Auscann Group Holdings Ltd (ASX: AC8) up between 60% and more than 100% over the 2017.

But you won’t get high on these companies’ profits. Because they don’t have any.

That’s why serious investors looking to profit from the growth of the medical cannabis space should look to companies that are already posting substantial revenues and profits, with wide distribution networks.

I have flagged a couple of times over the course of 2017 that vitamin maker Blackmores is likely to move into the medical cannabis sector and this week it confirmed that it is to “partner with the leaders in the research and cultivation of medicinal cannabis”. The likely outcome being commercial agreements to manufacture and sell cannabis-related products that could be popular with consumers.

More specifically the company plans to “seek authorisation to launch medical cannabis products through general practitioners and medical specialists” via its fast-growing Bioceuticals alternative and herbal therapies healthcare business.

For medicinal cannabis the vitamins maker has pinpointed the areas of palliative care, brain tumours and chronic pain as areas for clinical trials in an attempt to show the benefits of medical cannabis products.

Buy low, sell high?

The group is cycling off an especially strong FY 2016 in Australia that has seen group profits slump for the first nine-months of FY 2017, which has sent the share price into a prolonged downtrend.

However, its overseas and Bioceuticals businesses are still growing strongly and Blackmores looks a business with some long-term growth levers to pull.

Whether the medical cannabis ambitions can ever add meaningfully to earnings is hard to know, but given its strong track record and outlook I would not bet against Blackmores beating the market over the five years ahead.

Motley Fool contributor Tom Richardson owns shares of Blackmores Limited. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

asx share price competitions represented by businessmen arm wrestling
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

person reading news on mobile phone
⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »